Opioid-Free Shoulder Arthroplasty

• Status: Completed
• Trial end date: 2019-06-01
• Target enrollment: 0
• Participant gender: All

Summary

Purpose of Study:

To identify and provide a safe, opioid-free treatment pathway for shoulder arthroplasty with a focus on perioperative pain control and postoperative symptoms from treatment

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: OrthoCarolina Research Institute, Inc.
• Treatments: Acetaminophen; Analgesics, Opioid; Celecoxib; Desflurane; Gabapentin; Ketorolac; Ketorolac Tromethamine; Lidocaine; Propofol; Rocuronium; Sevoflurane; Vecuronium Bromide

Criteria

Inclusion Criteria:

1. Patient undergoing elective primary total shoulder or reverse total shoulder arthroplasty for osteoarthritis, avascular necrosis, cuff tear arthropathy, or inflammatory arthritis etiologies

2. Age greater than or equal to 50.

Exclusion Criteria:

1. Revision total shoulder arthroplasty

2. Chronic opioid therapy - per investigator discretion

3. Liver or renal insufficiency - per investigator discretion

4. Arthroplasty for fracture

5. Sickle cell disease

6. Workers compensation

7. Inability to receive block

8. Intervention Arm Only: Creatinine clearance less than 30 mL/min

9. Intervention Arm Only: Allergy to non-steroidal anti-inflammatory medications (NSAIDs).